These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19590142)

  • 1. Associations between metabolic syndrome and mortality from cardiovascular disease in Japanese general population, findings on overweight and non-overweight individuals. Ibaraki Prefectural Health Study.
    Irie F; Iso H; Noda H; Sairenchi T; Otaka E; Yamagishi K; Doi M; Izumi Y; Ota H
    Circ J; 2009 Sep; 73(9):1635-42. PubMed ID: 19590142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome and all-cause mortality, cardiac events, and cardiovascular events: a follow-up study in 25,471 young- and middle-aged Japanese men.
    Kondo T; Osugi S; Shimokata K; Honjo H; Morita Y; Yamashita K; Maeda K; Muramatsu T; Shintani S; Matsushita K; Murohara T
    Eur J Cardiovasc Prev Rehabil; 2011 Aug; 18(4):574-80. PubMed ID: 21450628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Syndrome for Cardiovascular Disease Morbidity and Mortality Among General Japanese People: A Mini Review.
    Watanabe J; Kotani K
    Vasc Health Risk Manag; 2020; 16():149-155. PubMed ID: 32368073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All-cause and cardiovascular disease mortality increased with metabolic syndrome in Taiwanese.
    Huang KC; Lee LT; Chen CY; Sung PK
    Obesity (Silver Spring); 2008 Mar; 16(3):684-9. PubMed ID: 18239592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of smoking and metabolic syndrome for incidence of cardiovascular disease--comparison of relative contribution in urban Japanese population: the Suita study.
    Higashiyama A; Okamura T; Ono Y; Watanabe M; Kokubo Y; Okayama A
    Circ J; 2009 Dec; 73(12):2258-63. PubMed ID: 19838005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome and all-cause and cardiovascular disease mortality: Japan Public Health Center-based Prospective (JPHC) Study.
    Saito I; Iso H; Kokubo Y; Inoue M; Tsugane S
    Circ J; 2009 May; 73(5):878-84. PubMed ID: 19282609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposed criteria for metabolic syndrome in Japanese based on prospective evidence: the Hisayama study.
    Doi Y; Ninomiya T; Hata J; Yonemoto K; Arima H; Kubo M; Tanizaki Y; Iwase M; Iida M; Kiyohara Y
    Stroke; 2009 Apr; 40(4):1187-94. PubMed ID: 19265058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolic syndrome increases cardiovascular mortality in Taiwanese elderly.
    Wen CJ; Lee YS; Lin WY; Huang HL; Yao CA; Sung PK; Huang KC
    Eur J Clin Invest; 2008 Jul; 38(7):469-75. PubMed ID: 18505405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic syndrome increased risk of cardiovascular events in Chinese--a community based study.
    Wang C; Hou X; Bao Y; Pan J; Zuo Y; Zhong W; Jia W; Xiang K
    Int J Cardiol; 2010 Mar; 139(2):159-65. PubMed ID: 19046783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort.
    Guembe MJ; Fernandez-Lazaro CI; Sayon-Orea C; Toledo E; Moreno-Iribas C;
    Cardiovasc Diabetol; 2020 Nov; 19(1):195. PubMed ID: 33222691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of age and gender on the prevalence and prognostic importance of the metabolic syndrome and its components in Europeans. The MORGAM Prospective Cohort Project.
    Vishram JK; Borglykke A; Andreasen AH; Jeppesen J; Ibsen H; Jørgensen T; Palmieri L; Giampaoli S; Donfrancesco C; Kee F; Mancia G; Cesana G; Kuulasmaa K; Salomaa V; Sans S; Ferrieres J; Dallongeville J; Söderberg S; Arveiler D; Wagner A; Tunstall-Pedoe H; Drygas W; Olsen MH;
    PLoS One; 2014; 9(9):e107294. PubMed ID: 25244618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.
    Lakka HM; Laaksonen DE; Lakka TA; Niskanen LK; Kumpusalo E; Tuomilehto J; Salonen JT
    JAMA; 2002 Dec; 288(21):2709-16. PubMed ID: 12460094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of moderate metabolic risk factor clustering to cardiovascular disease mortality in non-lean Japanese: a 15-year follow-up of NIPPON DATA90.
    Kadota A; Miura K; Okamura T; Hozawa A; Murakami Y; Fujiyoshi A; Takashima N; Hayakawa T; Kita Y; Okayama A; Nakamura Y; Ueshima H;
    Atherosclerosis; 2011 Mar; 215(1):209-13. PubMed ID: 21176834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Added value of different metabolic syndrome definitions for predicting cardiovascular disease and mortality events among elderly population: Tehran Lipid and Glucose Study.
    Mozaffary A; Bozorgmanesh M; Sheikholeslami F; Azizi F; Eskandari F; Hadaegh F
    Eur J Clin Nutr; 2014 Jul; 68(7):853-8. PubMed ID: 24865481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictive value of metabolic syndrome for cardiovascular and all-cause mortality: Tehran Lipid and Glucose Study.
    Amouzegar A; Mehran L; Hasheminia M; Kheirkhah Rahimabad P; Azizi F
    Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27155315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the diagnosis of metabolic syndrome useful for predicting cardiovascular disease in asian diabetic patients? Analysis from the Japan Diabetes Complications Study.
    Sone H; Mizuno S; Fujii H; Yoshimura Y; Yamasaki Y; Ishibashi S; Katayama S; Saito Y; Ito H; Ohashi Y; Akanuma Y; Yamada N;
    Diabetes Care; 2005 Jun; 28(6):1463-71. PubMed ID: 15920069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of metabolic syndrome on the development of cardiovascular disease in a general Japanese population: the Hisayama study.
    Ninomiya T; Kubo M; Doi Y; Yonemoto K; Tanizaki Y; Rahman M; Arima H; Tsuryuya K; Iida M; Kiyohara Y
    Stroke; 2007 Jul; 38(7):2063-9. PubMed ID: 17525396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population.
    He Y; Jiang B; Wang J; Feng K; Chang Q; Fan L; Li X; Hu FB
    J Am Coll Cardiol; 2006 Apr; 47(8):1588-94. PubMed ID: 16630995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
    Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
    Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.